Jinhong Chang Selected Research

Jinhong Chang Research Topics

Disease

40	Infections 01/2022 - 04/2007
16	Virus Diseases (Viral Diseases) 01/2022 - 05/2007
16	Chronic Hepatitis B 12/2021 - 09/2010
8	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 08/2008
4	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2022 - 01/2009
4	Hepatitis B 10/2020 - 12/2012
4	Bites and Stings (Sting) 12/2019 - 02/2015
4	Dengue (Dengue Fever) 01/2018 - 02/2012
3	Yellow Fever 10/2020 - 12/2016
3	Viral Hemorrhagic Fevers (Viral Hemorrhagic Fever) 01/2018 - 06/2013
3	Fever (Fevers) 01/2018 - 06/2013
2	Coronavirus Infections 01/2022 - 01/2020
2	Disease Progression 12/2021 - 08/2014
2	Neoplasms (Cancer) 12/2019 - 11/2017
2	Diarrhea 04/2013 - 04/2009
2	Viremia 11/2011 - 01/2011
1	COVID-19 01/2022
1	Flavivirus Infections 01/2022
1	Leukemia 01/2020
1	Carcinogenesis 10/2019
1	Lassa Fever (Fever, Lassa) 01/2019
1	Craniosynostoses (Craniosynostosis) 12/2018
1	Acrocephalosyndactylia (Apert Syndrome) 12/2018
1	Japanese Encephalitis 01/2018
1	Ebola Hemorrhagic Fever 01/2018
1	Marburg Virus Disease 02/2017
1	Body Weight (Weight, Body) 12/2016
1	Disease Susceptibility (Diathesis) 01/2015
1	Persistent Infection 08/2014
1	Common Cold 05/2014
1	Fibrosis (Cirrhosis) 06/2013
1	Inflammation (Inflammations) 01/2012

Drug/Important Bio-Agent (IBA)

36	Antiviral Agents (Antivirals)IBA 01/2022 - 02/2008
15	Proteins (Proteins, Gene)FDA Link 10/2020 - 05/2007
12	CytokinesIBA 01/2022 - 01/2009
9	InterferonsIBA 01/2022 - 08/2010
7	Pattern Recognition ReceptorsIBA 01/2022 - 01/2009
7	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 08/2014
6	GlucosidasesIBA 01/2018 - 01/2011
5	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2021 - 09/2015
5	Viral DNAIBA 10/2020 - 06/2013
4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022 - 01/2009
4	Interferon-alpha (Interferon Alfa)IBA 08/2014 - 02/2008
4	SugarsIBA 06/2013 - 04/2009
3	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2013
3	Interferon Type IIBA 01/2022 - 01/2012
3	VaccinesIBA 01/2022 - 12/2016
3	sodium-bile acid cotransporterIBA 12/2021 - 10/2017
3	Surface Antigens (Surface Antigen)IBA 02/2021 - 01/2017
3	Membrane Proteins (Integral Membrane Proteins)IBA 12/2019 - 08/2010
3	cyclic guanosine monophosphate-adenosine monophosphateIBA 12/2019 - 10/2017
3	Pharmaceutical PreparationsIBA 11/2017 - 03/2011
2	Viral AntigensIBA 12/2021 - 01/2017
2	AntibodiesIBA 12/2021 - 02/2021
2	Viral ProteinsIBA 12/2021 - 10/2019
2	Biological ProductsIBA 01/2020 - 07/2012
2	Interferon-gamma (Interferon, gamma)IBA 01/2020 - 09/2010
2	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2019 - 01/2016
2	glucosidase IIBA 01/2018 - 01/2015
2	ureido-N-hexyl deoxynojirimycinIBA 01/2018 - 02/2017
2	Tetracycline (Achromycin)FDA LinkGeneric 10/2017 - 09/2013
2	ProdrugsIBA 02/2017 - 09/2013
2	Imino SugarsIBA 06/2013 - 01/2011
1	Viral RNAIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Exonucleases (3' 5' Exonuclease)IBA 12/2021
1	Capsid Proteins (Capsid Protein)IBA 10/2020
1	STAT1 Transcription FactorIBA 01/2020
1	AntigensIBA 01/2020
1	platelet protein P47 (pleckstrin)IBA 01/2020
1	Protein SIBA 01/2020
1	EnzymesIBA 01/2019
1	Viral Envelope ProteinsIBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	AphidicolinIBA 01/2019
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 12/2018
1	2',3'-dideoxyguanosineIBA 12/2018
1	Firefly LuciferasesIBA 11/2017
1	LuciferasesIBA 11/2017
1	Circular DNAIBA 10/2017
1	LigandsIBA 10/2017
1	Janus KinasesIBA 10/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	benzamideIBA 01/2017
1	BenzodiazepinesIBA 12/2016
1	Nucleic Acid Synthesis InhibitorsIBA 01/2016
1	Ribonuclease H (RNase H)IBA 01/2016
1	pgRNAIBA 01/2016
1	ChemokinesIBA 02/2015
1	vadimezanIBA 02/2015
1	Toll-Like Receptor AgonistsIBA 02/2015
1	FluorineIBA 06/2013
1	AmidesIBA 04/2013
1	N-dodecyl-L-lysine amideIBA 04/2013
1	6H- 6- imino- (2,3,4,5- tetrahydropyrimido)(1,2- c)- (1,3)benzothiazineIBA 02/2012

Therapy/Procedure

16	Therapeutics 01/2022 - 02/2008
2	Immunotherapy 10/2017 - 01/2017
2	Oral Administration 12/2016 - 01/2011